
usd jan pm et
summari lead consum product compani market household person care product
countri
price-to-earnings oper ep
risk assess reflect stabl demand
household person care product
gener affect chang economi
geopolit factor except select categori
past perform indic futur perform reli upon
analysi prepar equiti analyst
jan stock trade
star recommend pg
recent chang buy
hold target price
recent chang
highlight section stock report
invest rationale/risk section
stock report updat shortli
latest news stori pg marketscop see
rais target price
base fy jun ep
estim slight premium compar peer
rais fy fy ep estim
respect pg
report dec ep vs
consensu organ
sale increas second consecut
quarter back organ growth
beauti segment due solid growth sk-ii
olay skin earn call pg
note sign slowdown china
net sale perspect
sale guidanc one point
see sign confid given
limit china exposur
forecast ep growth fy follow
growth fy current
dividend yield augment total return
potenti rais rate buy
fiscal year end jun ep estim base cfra
oper earn histor earn report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
chairman board
corpor overview procter gambl busi focus provid brand product
consid superior qualiti valu improv live world consum pg product sold
countri canada account total sale europ asia
pacif china latin america imea india middl east africa pg custom
includ mass merchandis groceri store membership club store drug store high-frequ
store sale store affili repres total fy revenu pg top
custom account total sale
compani five segment beauti fy net sale net earn groom
health care fabric home care babi feminin famili
impact major develop februari pg laid plan reduc cost billion
five year approxim billion cost reduct remaind cost control
leverag fix expens signific amount save expect come reduc overhead
expens includ elimin non-manufactur posit reduct
compani expect incur excess billion before-tax restructur cost fy fy
compani announc addit multi-year product cost save program
reduc cost area suppli chain market activ overhead expens
think cost save plan provid benefit oper margin expect much
mitig factor reinvest rise commod cost competit price mix
competit landscap think pg competit strength includ divers portfolio busi
scale strong brand billion annual sale pg benefit scale
provid greater sale opportun cost save compar peer analysi pg
substanti brand strength view retail consum howev note market
pg particip highli competit compani product vy similar
product mani larg small compani includ well-known global competitor well
retail privat label brand think product innov key growth driver industri although
pg success front limit recent year fy pg research develop
corpor strategi fy annual report pg outlin long-term annual growth target
includ organ sale growth exclud impact acquisit divestitur foreign exchang
fluctuat modestli market growth rate categori countri pg compet
growth core ep exclud certain one-tim item high singl digit
pg object deliv total sharehold return top one-third peer group focus
resourc biggest profit categori market includ strengthen grow
core market invest emerg market categori countri
largest opportun highest likelihood success alloc resourc busi
juli compani agre merg beauti segment brand inc
billion transact includ pg salon profession retail hair color cosmet fine fragranc
busi deal close octob
februari pg sold duracel busi berkshir hathaway exchang billion pg
share held berkshir transact valu deal fy ev/ebitda valu
equival all-cash sale valu adjust tax-effici structur deal pg
previous announc octob intent exit duracel busi prefer
spin busi stand-alon compani unless favor divestitur option emerg
fy pg announc enter agreement acquir counter over-the-counter healthcar
busi merck billion transact replac healthcar partnership pg
teva pharmaceut transact greatli expand pg over-the-counter presenc number european
countri present great opportun bring product north american market
financi trend pg report fy organ sale increas net sale increas
organ volum growth posit foreign currenc impact fy gross margin fell
basi point basi point increas reduct manufactur cost off-set basi
point increas raw materi cost basi point reduct lower price basi point
reduct unfavor product mix basi point reduct unfavor foreign currenc
exchang basi point reduct volum restructur oper ep fy
fy fy pg made stock repurchas total billion billion
repurchas fy
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
pg overvalu usd
neutral sinc januari technic indic pg
neutral
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million usd
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
posit fundament outlook
household product sub-industri next
month reflect opportun increas
exposur defens sub-industri
robust dividend yield strong free cash
flow view see margin
improv commod price
transport cost recov rough
raw materi use household product
crude oil chemic industri
product fiber notabl
commod price increas price pulp
pulp increas
core raw materi use napkin paper towel
toilet paper diaper feminin pad
manufactur hand rais price
averag calcul
goe show much industri
absorb high input cost rather
pass cost consum led
lower realiz margin
think price stabil global
economi slow recent period high
suppli rise due increas product
capac see sign relief
tariff china
also help drive raw materi
price
freight cost also particularli
higher due strong demand back tight
labor market gave price power
linehaul index track per-mil truckload
linehaul rate independ fuel note
year-over-year increas freight rate
novemb expect freight cost
continu headwind stem
driver shortag truck industri
continu growth retail e-commerc
sale view driver shortag
continu due age workforc increas
regul consecut drive hour
high driver turnov rate
transportation-rel cost may see
pressur eas due recent dip crude
oil price late
household product industri compet
highli competit landscap sever
product offer small larg
brand product well
retail private-label brand compar
fast-mov consum packag good
product like packag food believ
private-label brand present less threat
household good industri partial due
less premium privat label brand avail
marketplac sign slow consum
think one key factor growth
success industri innov
abil expand geograph presenc
develop market market
satur disruptive-styl
innov tactic identifi consum
trend time effici remain critic
maintain grow market share
 household product index fell
versu declin
 household product
increas compar
rise note
procter gambl weight
sub-industri index
base index
five-year market price perform jan
note sector sub-industri inform base
past perform indic futur perform
reli upon
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
gambl compani pg trim target price
fy jun ep estim slight discount three-year
histor averag price-to-earnings lower fy ep estim
set fy pg report jun-q oper ep vs
consensu jun-q sale increas driven growth beauti
volum growth growth fabric despit
decreas price believ pg take necessari step turn
busi around especi within groom babi feminin famili
segment impact entranc low-cost
competitor gross margin fell manufactur cost save effort
off-set addit commodity/ship cost unfavor price
product mix see sale growth fy driven mostli increas
volum price expect headwind first half tailwind
second half /keith snyder
gambl compani pg keep target price
fy jun ep estim line five-year histor
averag price-to-earnings reflect stabl sale growth margin
expect maintain fy ep estim rais fy
pg report mar-q oper ep vs
consensu mar-q organ sale increas driven
growth beauti partial off-set declin babi feminin
famili pg announc termin jv teva pharmaceut
juli two compani reach conclus prioriti
strategi longer align pg replac jv purchas
consum busi merck kgaa euro transact
subject customari close condit regulatori approv expect
close fy see deal posit pg given expand
over-the-counter product offer geograph footprint /keith snyder
analyst research note compani news
pm et cfra rais rate share procter gambl
compani buy hold pg rais target price
base fy jun ep estim slight premium
compar peer rais fy fy ep estim
respect pg report dec ep vs
consensu organ sale increas
second consecut quarter back organ growth beauti segment
due solid growth sk-ii olay skin earn call
pg note sign slowdown china net sale
perspect consum said pg rais fy organ sale guidanc
one point see sign confid given numer
macroeconom headwind go limit china exposur
forecast ep growth fy follow growth fy
current dividend yield augment total return potenti rais
rate buy defens consum stapl name /arun sundaram
et cfra lower opinion share procter gambl
compani hold buy pg rais target price
fy jun ep estim multipl
slight premium peer averag compar ten-year histor
averag price-to-earnings reflect sale improv across number key
brand believ pg done good job turn around mani core
brand especi within groom segment sourc
weak past year share trade close
target price believ prudent move hold recommend
still number headwind limit abil appli higher
multipl share still project sale declin fy due partli
weak babi feminin famili segment sluggish demand
develop market addit pg continu experi margin
pressur rise input/transport cost offset save
et cfra reiter buy opinion share procter
 gambl compani pg late last week pg held investor
day compani affirm growth strategi provid notic brand
leadership drive improv product cost save support
innov margin transform compani organ cultur
begin juli compani oper simpler
organiz structur six industry-bas busi unit beauti babi
feminin care fabric home care famili care groom health care
largest geograph market ceo report compani
chairman ceo david taylor accordingli pg continu reduc
corpor resourc corpor work shift busi
unit cfo jon moeller respons expand includ vice chairman
role market beyond busi unit think chang
make sens would enabl pg focu oper effici
success see relat layoff like /keith snyder scott kessler
gambl compani pg rais target price
fy jun ep estim slight premium peer averag
three-year forward averag price-to-earnings reflect strong result
recent success price increas trim fy ep estim
increas fy pg report sep-q
oper ep vs consensu sep-q organ
sale increas growth beauti segment double-digit growth
skin person driven increas market invest
premium innov result groom segment
stronger-than-expect organ volum growth organ sale
growth despit continu challeng valu share competit project
sale declin fy increas volum uncertainti volatil
offset posit price trend throughout year /keith snyder
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim pg earn
usd quarter fiscal year pg
announc earn per share usd repres
total revenu estim fiscal year
analyst estim pg earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
